#BEGIN_DRUGCARD DB04199

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C9H19O7P

# Chemical_IUPAC_Name:
[(2S)-3-(hexanoyloxy)-2-hydroxypropoxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate

# HET_ID:
HHG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H19O7P/c1-2-3-4-5-9(11)15-6-8(10)7-16-17(12,13)14/h8,10H,2-7H2,1H3,(H2,12,13,14)/t8-/m0/s1

# InChI_Key:
InChIKey=FIMVTNBZKNVWDN-QMMMGPOBSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4199

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
270.2167

# Molecular_Weight_Mono:
270.086839474

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Y9T

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.03

# Predicted_LogS:
-1.5

# Predicted_Water_Solubility:
8.94e+00 g/l

# Primary_Accession_No:
DB04199

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
657119

# PubChem_Substance_ID:
46506979

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01744

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@](O)(COC(=O)CCCCC)COP(O)(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:05 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell outer membrane
lipid-anchor (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D50601

# Drug_Target_1_GenBank_ID_Protein:
829069

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mxiM

# Drug_Target_1_Gene_Sequence:
>429 bp
ATGATTCGACATGGTAGTAATAAGTTGAAAATATTTATTTTAAGTATATTGCTATTAACA
CTGAGTGGGTGTGCTTTAAAGTCATCATCTAATTCTGAAAAAGAATGGCATATTGTTCCT
GTAAGTAAGGATTATTTTTCTATTCCAAATGATTTATTATGGTCGTTTAATACAACCAAT
AAAAGTATAAATGTTTACTCTAAATGTATTAGTGGTAAGGCGGTTTATAGTTTTAATGCA
GGTAAATTCATGGGCAACTTTAATGTTAAGGAAGTAGATGGGTGCTTCATGGATGCACAA
AAGATAGCTATAGATAAACTATTTTCTATGCTGAAAGACGGGGTTGTTTTAAAAGGTAAT
AAGATAAATGATACCATCCTTATAGAGAAGGATGGGGAAGTTAAATTAAAATTAATTCGA
GGGATATAA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3033

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
15853

# Drug_Target_1_Name:
Lipoprotein mxiM

# Drug_Target_1_Number_of_Residues:
142

# Drug_Target_1_PDB_ID:
1Y9T

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Lipoprotein mxiM precursor
MIRHGSNKLKIFILSILLLTLSGCALKSSSNSEKEWHIVPVSKDYFSIPNDLLWSFNTTN
KSINVYSKCISGKAVYSFNAGKFMGNFNVKEVDGCFMDAQKIAIDKLFSMLKDGVVLKGN
KINDTILIEKDGEVKLKLIRGI

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-23

# Drug_Target_1_Specific_Function:
Involved in the secretion of the Ipa antigens

# Drug_Target_1_SwissProt_ID:
P0A1X3

# Drug_Target_1_SwissProt_Name:
MXIM_SHISO

# Drug_Target_1_Synonyms:
Lipoprotein mxiM precursor

# Drug_Target_1_Theoretical_pI:
9.90

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cell outer membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M98391

# Drug_Target_2_GenBank_ID_Protein:
152770

# Drug_Target_2_GeneCard_ID:
mxiM

# Drug_Target_2_Gene_Name:
mxiM

# Drug_Target_2_Gene_Sequence:
>429 bp
ATGATTCGACATGGTAGTAATAAGTTGAAAATATTTATTTTAAGTATATTGCTATTAACA
CTGAGTGGGTGTGCTTTAAAGTCATCATCTAATTCTGAAAAAGAATGGCATATTGTTCCT
GTAAGTAAGGATTATTTTTCTATTCCAAATGATTTATTATGGTCGTTTAATACAACCAAT
AAAAGTATAAATGTTTACTCTAAATGTATTAGTGGTAAGGCGGTTTATAGTTTTAATGCA
GGTAAATTCATGGGCAACTTTAATGTTAAGGAAGTAGATGGGTGCTTCATGGATGCACAA
AAGATAGCTATAGATAAACTATTTTCTATGCTGAAAGACGGGGTTGTTTTAAAAGGTAAT
AAGATAAATGATACCATCCTTATAGAGAAGGATGGGGAAGTTAAATTAAAATTAATTCGA
GGGATATAA

# Drug_Target_2_General_Function:
Involved in pathogenesis

# Drug_Target_2_General_References:
11115111	Buchrieser C, Glaser P, Rusniok C, Nedjari H, D'Hauteville H, Kunst F, Sansonetti P, Parsot C: The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol Microbiol. 2000 Nov;38(4):760-71.
11292750	Venkatesan MM, Goldberg MB, Rose DJ, Grotbeck EJ, Burland V, Blattner FR: Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri. Infect Immun. 2001 May;69(5):3271-85.
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
1332940	Allaoui A, Sansonetti PJ, Parsot C: MxiJ, a lipoprotein involved in secretion of Shigella Ipa invasins, is homologous to YscJ, a secretion factor of the Yersinia Yop proteins. J Bacteriol. 1992 Dec;174(23):7661-9.
14573649	Lan R, Stevenson G, Reeves PR: Comparison of two major forms of the Shigella virulence plasmid pINV: positive selection is a major force driving the divergence. Infect Immun. 2003 Nov;71(11):6298-306.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6617

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
15852.5

# Drug_Target_2_Name:
Lipoprotein mxiM

# Drug_Target_2_Number_of_Residues:
142

# Drug_Target_2_PDB_ID:
1Y9T

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
>Lipoprotein mxiM
MIRHGSNKLKIFILSILLLTLSGCALKSSSNSEKEWHIVPVSKDYFSIPNDLLWSFNTTN
KSINVYSKCISGKAVYSFNAGKFMGNFNVKEVDGCFMDAQKIAIDKLFSMLKDGVVLKGN
KINDTILIEKDGEVKLKLIRGI

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-23

# Drug_Target_2_Specific_Function:
Involved in the secretion of the Ipa antigens

# Drug_Target_2_SwissProt_ID:
P0A1X2

# Drug_Target_2_SwissProt_Name:
MXIM_SHIFL

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
9.90

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE005174

# Drug_Target_3_GenBank_ID_Protein:
12512676

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
ECs4578

# Drug_Target_3_Gene_Sequence:
>84 bp
ATGAAACGCATTAGCACCACCATTACCACCACCATCACCACCACCATCACCATTACCATT
ACCACAGGTAACGGTGCGGGCTGA

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
11206551	Perna NT, Plunkett G 3rd, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR: Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 2001 Jan 25;409(6819):529-33.
11258796	Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, Han CG, Ohtsubo E, Nakayama K, Murata T, Tanaka M, Tobe T, Iida T, Takami H, Honda T, Sasakawa C, Ogasawara N, Yasunaga T, Kuhara S, Shiba T, Hattori M, Shinagawa H: Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 2001 Feb 28;8(1):11-22.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6618

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
13929.0

# Drug_Target_3_Name:
GrlR

# Drug_Target_3_Number_of_Residues:
123

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
>GrlR
MIMKDGIYSIIFISNEDSCGEGILIKNGNMITGGDIASVYQGVLSEDEDIILHVHRYNYE
IPSVLNIEQDYQLVIPKKVLSNDNNLTLHCHVRGNEKLFVDVYAKFIEPLVIKNTGMPQV
YLK

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q7DB61

# Drug_Target_3_SwissProt_Name:
Q7DB61_ECO57

# Drug_Target_3_Synonyms:
SubName: Putative uncharacterized protein
SubName: Putative uncharacterized protein ECs4578

# Drug_Target_3_Theoretical_pI:
4.85

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB04199
